On November 11, 2020 Revive Therapeutics (RVV.C) Revive Therapeutics updated shareholders on its oral thin-film delivery system with psilocybin being developed “under a research partnership agreement with Reed Research…
clinical trials
Nextleaf Solutions (OILS.C) received confirmation of their second patent for the acetylation of cannabinoids from the United States Patent and Trademark Office today, according to a press release. The…
It would seem the race to find a suitable treatment for COVID-19 is over, as Gilead Sciences (GILD.Q) announced today that their antiviral drug Veklury (remdesivir) received the nod…
Revive Therapeutics (RVV.C) recent supply agreement with HAVN Life Sciences (HAVN.C) will give them a steady supply of naturally derived psychedelic compounds, like psilocybin, to be used in any…
Medipharm Labs Inc, a subsidiary of Medipharm Labs (LABS.T), kicked off a clinical trial to determine the effectiveness of Medipharm Labs’ medical cannabis products and formulations on treating end-stage…
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focused on developing coronavirus solutions….
Normally when we we write about Revive Therapeutics (RVV.C), it’s generally to provide an update on their progress regarding their experimental COVID-19 palliative, Bucillamine. This update isn’t that, and…
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focussed on developing coronavirus solutions….
Revive has a partnership agreement with the Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin….
The ongoing COVID-19 drama that’s dragged markets to its knees may almost be over, as finally companies have made some headway and there’s a drug out there that’s been…